Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bill Ackman

Last week, billionaire activist investor Bill Ackman‘s Pershing Square released a letter to shareholders, in which the investor outlined the fund’s performance and provided his take on the outlook of some of the companies that Pershing Square has bet on. In the first part (read here), we mentioned Pershing’s returns, which have been lagging lately and took a look at Ackman’s short position in Herbalife, as well two of its largest holdings: Valeant Pharmaceuticals and Air Products and Chemicals. Let’s take a look at several other companies that Ackman discussed in his letter.

Bill Ackman
Bill Ackman
Pershing Square

Let’s start with Mondelez International Inc (NASDAQ:MDLZ), which represented Pershing’s second-largest detractors, having negatively affected Pershing’s return by 3.5% in the first three months of 2016. With a $1.94 billion position that contained 43.37 million shares, Mondelez represented Pershing’s third-largest stake at the end of 2015. However, in March, Pershing unloaded 20.0 million shares of the company for portfolio management reasons and currently owns 5.7% of the company. Mondelez International Inc (NASDAQ:MDLZ)’s stock has plunged by over 10% during the first quarter, but has rebounded in April and is currently 1% in the red year-to-date. Ackman considers that Mondelez’ 2018 target margins of 17% to 18% will considerably increase the company’s value.

“This target reflects some of the steps the company has taken over the last several years to improve its supply chain, reduce portfolio complexity, and rationalize overhead while increasing advertising and promotion. While we believe that the business is capable of higher margins, if Mondelez were to only achieve management’s target, the business would be worth significantly more than its current public market valuation.”

Follow Mondelez International Inc. (NASDAQ:MDLZ)
Trade (NASDAQ:MDLZ) Now!

Nomad Foods (NYSE:NOMD) is another food company that Ackman mentioned in the letter, highlighting the acquisitions of Iglo and Findus, which transformed Nomad into the largest branded frozen food company. The stock has lost over 31% year-to-date, but the investor considers that the company will continue the consolidation of the packaged food segment over the long-run and will focus on the integration of its latest acquisitions and on achieving synergy targets in the near-term. In the first quarter, Nomad Foods (NYSE:NOMD) had a negative contribution to Pershing’s returns of 0.7%.

“Recent performance has shown weak top-line trends, with like-for-like sales down 5% for 2015, the result of Iglo’s historic strategy which was to disproportionately invest behind new frozen food categories, at the expense of core offerings, in the hope of driving incremental growth. Recently, Nomad has shifted its focus back to its core offerings. This shift will take some time to impact the Company’s financial performance, but ultimately we believe it will result in renewed growth,” Ackman said.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.